246 related articles for article (PubMed ID: 35371039)
1. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
4. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
5. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
[TBL] [Abstract][Full Text] [Related]
6. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Bonacci M; Lens S; Londoño MC; Mariño Z; Cid MC; Ramos-Casals M; Sánchez-Tapias JM; Forns X; Hernández-Rodríguez J
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia.
Chang ML; Cheng JS; Chen WT; Hsu CW; Chen KH; Chen YC; Chien RN
J Infect Public Health; 2024 Mar; 17(3):486-494. PubMed ID: 38280352
[TBL] [Abstract][Full Text] [Related]
8. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
9. Evolution of ferritin levels in hepatitis C patients treated with antivirals.
Chang ML; Hu JH; Yen CH; Chen KH; Kuo CJ; Lin MS; Lee CH; Chen SC; Chien RN
Sci Rep; 2020 Nov; 10(1):19744. PubMed ID: 33184464
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
11. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
14. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.
Passerini M; Schiavini M; Magni CF; Landonio S; Niero F; Passerini S; Croci AL; Bolis M; Scalzi V; Gubertini G; Ricci ED; Galli M; Rizzardini G
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1208-1215. PubMed ID: 30138160
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals.
Yokoyama K; Kino T; Nagata T; Miyayama T; Shibata K; Fukuda H; Yamauchi R; Fukunaga A; Umeda K; Takata K; Tanaka T; Shakado S; Sakisaka S; Imafuku S; Hirai F
Intern Med; 2023 Dec; 62(24):3631-3636. PubMed ID: 37121750
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
Cheng YT; Cheng JS; Lin CH; Chen TH; Lee KC; Chang ML
Clin Microbiol Infect; 2020 Mar; 26(3):366-372. PubMed ID: 31229596
[TBL] [Abstract][Full Text] [Related]
17. Clinico-immunological outcomes of HCV-cured cryoglobulinemia: Lower relapse rate with interferon-based than interferon-free therapy.
Colantuono S; Marrapodi R; Del Padre M; Collalti G; Garzi G; De Santis A; Fiorilli M; Basili S; Visentini M; Casato M
Liver Int; 2021 Jan; 41(1):70-75. PubMed ID: 33064930
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Kondili LA; Monti M; Quaranta MG; Gragnani L; Panetta V; Brancaccio G; Mazzaro C; Persico M; Masarone M; Gentile I; Andreone P; Madonia S; Biliotti E; Filomia R; Puoti M; Fracanzani AL; Laccabue D; Ieluzzi D; Coppola C; Rumi MG; Benedetti A; Verucchi G; Coco B; Chemello L; Iannone A; Ciancio A; Russo FP; Barbaro F; Morisco F; Chessa L; Massari M; Blanc P; Zignego AL
Hepatology; 2022 Jul; 76(1):220-232. PubMed ID: 34919289
[TBL] [Abstract][Full Text] [Related]
19. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review.
Obrișcă B; Jurubiță R; Sorohan B; Iliescu L; Baston C; Bobeică R; Andronesi A; Leca N; Ismail G
Clin Rheumatol; 2019 Dec; 38(12):3677-3687. PubMed ID: 31172367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
